Patient Guide: Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 18 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT04601857
Status: TERMINATED
Condition: Advanced and Metastatic Urothelial Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 18 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • San Francisco, California
  • • Boston, Massachusetts
  • • Detroit, Michigan
  • • And 15 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma - Join Clinical Trial NCTNCT04601857

How to Join This Clinical Trial - NCTNCT04601857

Learn how to participate in this PHASE2 trial studying an investigational therapy for Advanced and Metastatic Urothelial Cancer. Current status: TERMINATED.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced and Metastatic Urothelial Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced and Metastatic Urothelial Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
TERMINATED
Study Identifier
NCTNCT04601857 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

San Francisco, California 94158 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: Contact for availability

Clinical Research Site

Detroit, Michigan 48202 - United States

Status: Contact for availability

Clinical Research Site

Las Vegas, Nevada 89148 - United States

Status: Contact for availability

Clinical Research Site

Strasbourg, Bas-Rhin 67200 - France

Status: Contact for availability

Clinical Research Site

Marseille, Bouches-du-Rhône 13273 - France

Status: Contact for availability

Clinical Research Site

Dijon, Côte d'Or 21079 - France

Status: Contact for availability

Clinical Research Site

Lyon, Rhone 69373 - France

Status: Contact for availability

Clinical Research Site

Vandœuvre-lès-Nancy, 54500 - France

Status: Contact for availability

Clinical Research Site

Villejuif, 94805 - France

Status: Contact for availability

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Advanced and Metastatic Urothelial Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation